NSECredit Rating8 Sept 2026 · 8 Sept 2026, 05:16 pm
Credit Rating
Tatva Chintan Pharma Chem Limited · TATVA
✦ AI Summary▲ Positivecredit_rating
Tatva Chintan Pharma Chem Limited has informed the Exchange about Credit Rating. CRISIL Ratings Limited has revised the ratings of the Company, upgrading the Long Term Rating to A-/Stable and the Short Term Rating to A2+.
Analysis Scores
Earnings Impact2/10
Growth Catalyst6/10
Governance Concern1/10
Regulatory Risk2/10
Balance Sheet Risk5/10
Liquidity Impact8/10
Market Sentiment9/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
Tatva Chintan Pharma Chem Limited has informed the Exchange about Credit Rating
Attachments (1)
📄pdf
Download →
TATVA_08092026171628_CF.pdf
View document text
Date:08September2026 Ref.No.:TCPCL/SEC/2026-27/00043
TheGeneralManager, TheManager,
Corporaterelationshipdepartment, Listingdepartment,
BSELimited NationalStockExchangeofIndiaLimited
PhirozeJeejeebhoyTowers, ExchangePlaza,C-1,Block-G,
DalalStreet,Fort, Bandra-KurlaComplex,Bandra(E),
Mumbai-400001 Mumbai-400051
ScripCode:543321 ScripSymbol:TATVA
Subject:IntimationofRevisioninCreditRating
DearSir/Madam,
Pursuant to Regulation 30 read with Schedule III of SEBI (Listing Obligations and
Disclosure Requirements) Regulations,2015(the“SEBIListingRegulations"),asamended,
we wish toinform that CRISIL Ratings Limited hasrevised the ratings of the Company, as
percommunicationreceivedon08September2026(copyenclosed),asunder:
Facility Previous RevisedRating RatingAction
Rating
Long CRISIL CRISIL Rating upgraded and Outlook revised
Term BBB+/Stable A-/Stable from CRISIL BBB+/Stable to
CRISILA-/Stable
Short CRISILA2 CRISILA2+ Rating upgraded and Outlook revised
Term fromCRISILA2toCRISILA2+
The above information shall be uploaded on the website of the Company at
www.tatvachintan.com.
Youarerequestedtokindlytakethesameonrecord.
Thankingyou,
Yoursfaithfully,
ForTatvaChintanPharmaChemLimited
AjeshPillai
ChiefFinancialOfficer
Encl.:Asabove
CONFIDENTIAL
RL/TCPCPLTD/405030/BLR/0926/158457
September 08, 2026
Mr. Ajesh Pillai
Chief Financial Officer
Tatva Chintan Pharma Chem Limited
Plot No. 502\/17, 502\/18, 502\/8, GIDC
GIDC, Ankleshwar
Vadodara - 390010
6352615619
Dear Mr. Ajesh Pillai,
Re: Review of Crisil Ratings on the bank facilities of Tatva Chintan Pharma Chem Limited
All ratings assigned by Crisil Ratings are kept under continuous surveillance and review.
Please find in the table below the ratings outstanding for the debt instruments/facilities of the company, and the rating actions by
Crisil Ratings on the ratings as on date.
Total Bank Loan Facilities Rated Rs.245 Crore
Long Term Rating Crisil A-/Stable (Upgraded from 'Crisil BBB+ / Stable')
Short Term Rating Crisil A2+ (Upgraded from 'Crisil A2 ')
(Bank-wise details as per Annexure 1)
As per our Rating Agreement, Crisil Ratings would disseminate the ratings, along with the outlook, through its publications and
other media, and keep the ratings, along with the outlook, under surveillance over the life of the instrument/facility. Crisil Ratings
reserves the right to withdraw, or revise the ratings, along with the outlook, at any time, on the basis of new information, or
unavailability of information, or other circumstances which Crisil Ratings believes may have an impact on the ratings. Please visit
www.crisilratings.com and search with the name of the rated entity to access the latest rating/s.
In the event of the company not availing the proposed facilities within a period of 180 days from the date of this letter, a fresh
letter of revalidation from Crisil Ratings will be necessary.
Crisil Ratings products / activities or ratings of instruments other than securities that are listed or proposed to be listed may fall
under the purview of financial sector regulators (FSRs) other than SEBI. In respect of such products / activities or ratings (under
the purview of other FSRs such as Reserve Bank of India (RBI), Ministry of Corporate Affairs (MCA), Insurance Regulatory and
Development Authority of India (IRDAI), among others), the grievance / dispute redressal and investor protection mechanisms
available under SEBI regulations shall not be applicable. A list of products/activities or ratings of instruments falling under the
purview of various FSRs along with the names of respective FSRs has been duly disclosed by Crisil Ratings on its website.
A link to the same has been provided below for ready reference:
https://www.crisilratings.com/en/home/our-business/ratings/regulatory-disclosures/list-of-activities-instruments-and-names-of-
regulators.html
This letter will remain valid till March 31, 2027. After this date, please insist for a new rating letter (dated later than March 31,
2027).
Should you require any clarification, please feel free to get in touch with us.
With warm regards,
Yours sincerely,
Shalaka Singh Nivedita Shibu
Associate Director - Crisil Ratings Director - Crisil Ratings
Disclaimer: A rating by Crisil Ratings reflects Crisil Ratings’ current opinion on the likelihood of timely payment of the obligations under the rated instrument, and does not constitute an audit of the rated entity by Crisil
Ratings. Our ratings are based on information provided by the issuer or obtained by Crisil Ratings from sources it considers reliable. Crisil Ratings does not guarantee the completeness or accuracy of the information on
which the rating is based. A rating by Crisil Ratings is not a recommendation to buy / sell or hold the rated instrument; it does not comment on the market price or suitability for a particular investor. Crisil Ratings has a
practice of keeping all its ratings under surveillance and ratings are revised as and when circumstances so warrant. Crisil Ratings is not responsible for any errors and especially states that it has no financial liability
whatsoever to the subscribers / users / transmitters / distributors of its ratings. Crisil Ratings’ criteria are available without charge to the public on the web site, www.crisilratings.com. Crisil Ratings or its associates may
have other commercial transactions with the company/entity. For the latest rating information on any instrument of any company rated by Crisil Ratings, please visit www.crisilratings.com or contact Customer Service
Helpdesk at Crisilratingdesk@crisil.com or at 1800-267-3850
Annexure 1 - Bank-wise details of various facility classes (outstanding facilities)
Amount (Rs.
S.No. Bank Facility Bank Outstanding Rating
in Crore)
1 Fund-Based Facilities Citibank N. A. 85 Crisil A-/Stable
2 Fund-Based Facilities State Bank of India 40 Crisil A-/Stable
3 Fund-Based Facilities ICICI Bank Limited 60 Crisil A-/Stable
4 Fund-Based Facilities DBS Bank Limited 35 Crisil A-/Stable
Letter of credit & Bank
5 ICICI Bank Limited 5.5 Crisil A2+
Guarantee
Letter of credit & Bank
6 State Bank of India 5 Crisil A2+
Guarantee
7 Proposed Term Loan -- 14.5 Crisil A-/Stable
Total 245
Annexure: List of instruments and names of regulators of the instruments
As required by SEBI CRA Circular dated Feb 10, 2026, a list of activities or instruments falling under the purview of various FSRs, along with the names of respective
FSRs, is being disclosed below:
A. Rating activities
Sr. No. Instrument / activity Name Regulator of the instruments
1 Listed/Proposed to be listed bonds/debentures/preference share (all securities) SEBI
2 Unlisted/Proposed to be unlisted Bonds/Debentures/ Preference share (all securities) MCA
3 Listed PTCs / Securitisation Notes (originated by entities regulated by RBI)* $. RBI
4 Listed PTCs / Securitisation Notes (originated by entities not regulated by RBI)* SEBI
5 Unlisted PTCs / Securitisation Notes (originated by entities regulated by RBI)* RBI
6 Listed Commercial Paper and NCDs with original maturity less than 1 year RBI
7 Unlisted Commercial Paper and NCDs with original maturity less than 1 year RBI
8 Loan Facilities (Fund/Non-Fund Based) from Bank/NBFCs/NHB/FIs ^ RBI
9 External Commercial Borrowings and other similar borrowings RBI
10 Certificates of Deposit RBI
11a Fixed Deposits raised by NBFCs,HFCs, FIs RBI
11b Fixed Deposits raised by Banks +
12 Fixed Deposits raised by corporates other than NBFCs, Banks, HFCs, FIs MCA
13 Inter Corporate Deposits/Loans extended by Corporates MCA
14 Borrowing programme ~ -
15 Issuer Ratings # -
16 Credit Ratings for Capital Protection Oriented Schemes (by Mutal Funds and AIFs) SEBI
17 Credit quality ratings (CQRs) for Mutual Fund Schemes and Schemes of AIFs SEBI
18 Listed Security Receipts $. RBI
19 Unlisted Security Receipts RBI
20 Independent Credit Evaluation (ICE) RBI
21 Expected Loss Ratings (for Loan Facilities (Fund/Non-Fund Based) from Bank/NBFCs/NHB/Fis) +
22 Expected Loss Ratings (Listed/Pr
[Showing first 8,000 characters — download PDF for full document]